Antidepressants and somatic symptoms: therapeutic actions are expanding beyond affective spectrum disorders to functional somatic syndromes.
Having expanded their original role as primary treatment for depression to preferred treatment for anxiety disorders, antidepressants are now emerging as potential therapeutic agents for many other disorders characterized by distressing or even painful somatic symptoms.
Stahl
Stephen M
SM
Neuroscience Education Institute in Carlsbad, CA 92009, USA.
D000928:Antidepressive Agents / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D019964:Mood Disorders / Q000188:drug therapy* / Q000503:physiopathology; D009638:Norepinephrine / Q000378:metabolism; D012701:Serotonin / Q000378:metabolism; D013001:Somatoform Disorders / Q000188:drug therapy* / Q000503:physiopathology
D000928:Antidepressive Agents; D012701:Serotonin; D009638:Norepinephrine